SI3565552T1 - Izboljšan postopek za pripravo rivaroksabana, ki vključuje nov intermediat - Google Patents

Izboljšan postopek za pripravo rivaroksabana, ki vključuje nov intermediat

Info

Publication number
SI3565552T1
SI3565552T1 SI201731183T SI201731183T SI3565552T1 SI 3565552 T1 SI3565552 T1 SI 3565552T1 SI 201731183 T SI201731183 T SI 201731183T SI 201731183 T SI201731183 T SI 201731183T SI 3565552 T1 SI3565552 T1 SI 3565552T1
Authority
SI
Slovenia
Prior art keywords
rivaroxaban
preparation
improved process
novel intermediate
involving novel
Prior art date
Application number
SI201731183T
Other languages
English (en)
Inventor
Dhananjay G. Sathe
Arijit Das
Sanjay Raikar
Yashwant S. SURVE
Bhushan S. Pandit
Original Assignee
Unichem Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unichem Laboratories Ltd filed Critical Unichem Laboratories Ltd
Publication of SI3565552T1 publication Critical patent/SI3565552T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
SI201731183T 2017-01-04 2017-12-21 Izboljšan postopek za pripravo rivaroksabana, ki vključuje nov intermediat SI3565552T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201721000351 2017-01-04
PCT/IB2017/058245 WO2018127762A1 (en) 2017-01-04 2017-12-21 An improved process for the preparation of rivaroxaban involving novel intermediate
EP17890544.4A EP3565552B1 (en) 2017-01-04 2017-12-21 An improved process for the preparation of rivaroxaban involving novel intermediate

Publications (1)

Publication Number Publication Date
SI3565552T1 true SI3565552T1 (sl) 2022-10-28

Family

ID=62789497

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201731183T SI3565552T1 (sl) 2017-01-04 2017-12-21 Izboljšan postopek za pripravo rivaroksabana, ki vključuje nov intermediat

Country Status (5)

Country Link
US (2) US11034683B2 (sl)
EP (1) EP3565552B1 (sl)
ES (1) ES2923932T3 (sl)
SI (1) SI3565552T1 (sl)
WO (1) WO2018127762A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6514143B2 (ja) * 2016-05-18 2019-05-15 Hoya株式会社 フォトマスクの製造方法、フォトマスク、及び表示装置の製造方法
CN110054623A (zh) * 2019-05-29 2019-07-26 浙江燎原药业股份有限公司 一种利伐沙班中间体的制备方法
CN114216976B (zh) * 2021-11-30 2024-04-30 江苏中邦制药有限公司 高效液相色谱法测定利伐沙班中潜在基因毒性杂质的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
US20070004712A1 (en) 2001-12-21 2007-01-04 Dr. Reddy's Laboratories Ltd. Salts of novel heterocyclic compounds having antibacterial activity
WO2013053739A1 (en) * 2011-10-10 2013-04-18 Laboratorios Lesvi, S. L. Process for preparing factor xa inhibitors
AU2012378913B2 (en) 2012-05-02 2017-04-13 Symed Labs Limited Improved process for preparing rivaroxaban using novel intermediates
CN105085370B (zh) * 2014-04-22 2017-04-12 北大方正集团有限公司 (s)‑1‑卤代‑2‑[2‑(1,3‑二氧异吲哚)基]乙基氯甲酸酯及其制备方法
WO2015198259A1 (en) 2014-06-26 2015-12-30 Erregierre S.P.A. Process for the synthesis of rivaroxaban and intermediate for the production thereof

Also Published As

Publication number Publication date
US11034683B2 (en) 2021-06-15
US20210387979A1 (en) 2021-12-16
WO2018127762A1 (en) 2018-07-12
US20200017487A1 (en) 2020-01-16
ES2923932T3 (es) 2022-10-03
US11891384B2 (en) 2024-02-06
EP3565552B1 (en) 2022-05-11
EP3565552A1 (en) 2019-11-13
EP3565552A4 (en) 2020-07-08

Similar Documents

Publication Publication Date Title
SI3433285T1 (sl) Izboljšan postopek za pripravo sugamadeksa
IL276917A (en) A process for the preparation of alubixivet
IL249933A0 (en) Process for preparing 3-(3-chloro-h1-pyrazol-1-yl)pyridine
ZA201706795B (en) Process for the preparation of dicycloplatin
IL260465B (en) A process for preparing an antibody-rifamycin conjugate
SI3717457T1 (sl) Postopek za pripravo enzalutamida z uporabo novega intermediara
IL261986B (en) An improved process for the preparation of butorphanol tartrate
SI3565552T1 (sl) Izboljšan postopek za pripravo rivaroksabana, ki vključuje nov intermediat
PL3765440T3 (pl) Sposób wytwarzania n-alkilonitratoetylonitroamin
EP3207041A4 (en) An improved process for the preparation of lurasidone hydrochloride
IL281254A (en) A process for the preparation of lanbatinib
IL275480A (en) A process for the preparation of pyrimidinyl-4-aminopyrazole compounds
PL3228619T3 (pl) Sposób wytwarzania apiksabanu
IL268835B (en) A process for the preparation of 2-cyanoimidazole compounds
ZA201808387B (en) Improved process for the preparation of carbamates
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
ZA202002116B (en) Process for the preparation of piperine
EP3877361C0 (en) PROCESS FOR PREPARING ARYLSULFONYLPROPENENITRILE
HUP1400378A2 (hu) Eljárás apixaban elõállítására
PL3728184T3 (pl) Sposób wytwarzania karbodiimidów
PL3599256T3 (pl) Sposób wytwarzania poliorganosiloksanów
PT3310711T (pt) Processo para a produção de cianeto de sódio
IL274487B1 (en) A process for the preparation of fluoficolide
ZA201901052B (en) Process for the preparation of hydrogen
HUP1800278A2 (en) Process for the preparation of boc-linagliptin